Francesca Puggioni

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 246 citations · Full text

The Severe Asthma Network in Italy: Findings and Perspectives

Enrico Heffler, Francesco Blasi, Manuela Latorre et al. · The Journal of Allergy and Clinical Immunology In Practice · 2018 · 164 citations · Full text

Asthma, Allergy, Clinical Epidemiology +5

Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

John W. Upham, Chantal Le Lievre, David J. Jackson et al. · The Journal of Allergy and Clinical Immunology In Practice · 2021 · 137 citations · Full text

Asthma, Allergy, Allergy Medicine +6

Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients

Enrico Heffler, Claudia Crimi, Salvatore Mancuso et al. · Respiratory Medicine · 2018 · 124 citations · Full text

Asthma, Primary Care, Pulmonary Care +5

Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry

Giorgio Walter Canonica, Giorgio Lorenzo Colombo, Giacomo Matteo Bruno et al. · World Allergy Organization Journal · 2019 · 115 citations · Full text